Expression of the LH2 gene in chronic myeloid leukaemia cells

Leukemia

Volumn 10, Issue 7, 1996, Pages 1122-1126

  Al Jehani, F ^a   Hochhaus, A ^a   Spencer, A ^a   Goldman, J M ^a   Melo, J V ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Chromosomal translocation; Chronic myeloid leukaemia; LH2; LIM HOX gene

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR;

ARTICLE; CHROMOSOME 9Q; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030015534     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. McWhirter JR, Wang JYJ. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol 1991; 11: 1553-1565.
2. Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR, Witte ON. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 1991; 11: 1785-1792.
3. Melo JV, Cordon DE, Cross NCP, Goldman JM. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 1993; 81: 158-165.
4. Gishinzky M, Witte ON. Initiation of deregulated growth of multipotent progenitor cells by bcr/abl in vitro. Science 1992; 256: 836-838.
5. bcr/abl gene of the Ph chromosome. Science 1990; 247: 824-829.
6. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 1990; 87: 6649-6653.
7. Lisker R, Casas L, Mutchinick O et al. Late appearing Ph chromosome in two patients with chronic myelogenous leukemia. Blood 1980; 56: 812-814.
8. Fialkow PJ, Martin PJ, Najfeld V et al. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 1981; 58: 125-130.
9. Cannistra SA. Chronic myelogenous leukaemia as a model for the genetic basis of cancer. Hematol/Oncol Clin N Am 1990; 4: 337-353.
10. Wu HK, Heng HHQ, Shi XM, Okuno Y, Dong WF, Tsui LC, Minden MD. High level of expression of a LIM/homeodomain gene, human LH-2, in chronic myelogenous leukemia mapped to the chromosome 9q33-34.1. Blood 1994; 84 (Suppl. 1): 2952.
11. Xu Y, Baldassare M, Fisher P, Rathbun G, Oltz EM, Yancopoulos GD, Jessell TM, Alt FW. LH2: a LIM/homeodomain gene expressed in developing lymphocytes and neural cells. Proc Natl Acad Sci USA 1993; 90: 227-231.
12. Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PCA, Allan NC, Hehlmann R, Goldman JM, Cross NCP. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-α therapy by competitive polymerase chain reaction. Blood 1996; 87: 1549-1555.
13. Keating A. Ph positive CML cell lines. Baillières Clin Haematol 1987; 1: 1021-1029.
14. Martin PJ, Najfeld V, Fialkow PJ. B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease. Cancer Genet Cytogenet 1982; 6: 359-368.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Cross NCP, Melo JV, Feng L, Goldman JM. An optimised multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186-189.
17. van Rhee FV, Marks DI, Lin F, Szydlo RM, Hochhaus A, Treleaven J, Delord C, Cross NCP, Goldman JM. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukaemia: comparison of blood and bone marrow. Leukemia 1995; 9: 329-335.
18. Melo JV, Yan XU, Diamond J, Goldman JM. Lack of imprinting of the ABL gene. Nat Genet 1994; 8: 318-319.
19. Melo JV, Yan XH, Diamond J, Goldman JM. Balanced parental contribution to the ABL component of the BCR-ABL gene in chronic myeloid leukemia. Leukemia 1995; 9: 734-745.
20. Goldman JM. Management of chronic myeloid leukaemia. Blood Reviews 1994; 8: 21-29.
21. Ahuja H, Bar EM, Arlin Z, Advani S, Allen SL, Goldman J, Snyder D, Foti A, Cline M. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J Clin Invest 1991; 87: 2042-2047.
22. Towatari M, Adachi K, Kato H, Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood 1991; 78: 2178-2181.
23. Sill H, Goldman JM, Cross NCP. Homozygous deletions of the P16 tumor suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 1995; 85: 2013-2016.